Pharmanews

Blueprint Medicines Corporation  a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on…

Summary : – Expands Blueprint Medicines’ lung cancer pipeline with LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion…

Summary : Granules India on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts…

Summary : Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapies, today announced the closing of the collaboration agreement with AstraZeneca…

Highlights: -Visiongain has published a new report on Antimicrobial Hospital Curtains Market Report to 2031. Market is segmented by type (Reusable antimicrobial…

Highlights: Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its clinical diversification plans to support global…

 Synopsis: Torrent Pharma announced that it is introducing MSD (a trade name of Merck & Co., Inc, Kenilworth, New Jersey, USA) and…

 Summary : – Medikabazaar, an online B2B platform for medical supplies, is looking to achieve a gross merchandise value (GMV) of around…

Summary : Rapid test to support the American public’s fight against the COVID-19 pandemic, with availability to purchase over-the-counter (OTC) at pharmacies…

Synopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced…